These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 26684336)

  • 21. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
    Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
    Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias.
    Iyer A; Zurolo E; Spliet WG; van Rijen PC; Baayen JC; Gorter JA; Aronica E
    Epilepsia; 2010 Sep; 51(9):1763-73. PubMed ID: 20345941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: Clinical and etiologic risk factors.
    Pillai SC; Mohammad SS; Hacohen Y; Tantsis E; Prelog K; Barnes EH; Gill D; Lim MJ; Brilot F; Vincent A; Dale RC
    Epilepsia; 2016 Jan; 57(1):e7-e11. PubMed ID: 26592968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
    Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
    Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epilepsy and brain inflammation.
    Vezzani A; Aronica E; Mazarati A; Pittman QJ
    Exp Neurol; 2013 Jun; 244():11-21. PubMed ID: 21985866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults.
    Vincent A; Bien CG
    Lancet Neurol; 2008 Dec; 7(12):1074-5. PubMed ID: 18851929
    [No Abstract]   [Full Text] [Related]  

  • 27. Brain inflammation in epilepsy: experimental and clinical evidence.
    Vezzani A; Granata T
    Epilepsia; 2005 Nov; 46(11):1724-43. PubMed ID: 16302852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune-mediated disorders.
    Höftberger R; Lassmann H
    Handb Clin Neurol; 2017; 145():285-299. PubMed ID: 28987176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti -NMDA receptor encephalitis].
    Iizuka T
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():607-12. PubMed ID: 26480765
    [No Abstract]   [Full Text] [Related]  

  • 30. The emerging role for chemokines in epilepsy.
    Fabene PF; Bramanti P; Constantin G
    J Neuroimmunol; 2010 Jul; 224(1-2):22-7. PubMed ID: 20542576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune and inflammatory epilepsies.
    Nabbout R
    Epilepsia; 2012 Sep; 53 Suppl 4():58-62. PubMed ID: 22946722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis.
    Specchio N; Fusco L; Claps D; Vigevano F
    Brain Dev; 2010 Jan; 32(1):51-6. PubMed ID: 19850427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor regulation of effector T lymphocyte function.
    Reynolds JM; Dong C
    Trends Immunol; 2013 Oct; 34(10):511-9. PubMed ID: 23886621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of immunity in the pathophysiology of intractable epilepsy-postencephalitic epilepsy & immunity].
    Takahashi Y; Yamaguchi T
    No To Hattatsu; 2014 May; 46(3):195-201. PubMed ID: 24902338
    [No Abstract]   [Full Text] [Related]  

  • 35. Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatment.
    Howell J; Angus P; Gow P; Visvanathan K
    J Gastroenterol Hepatol; 2013 May; 28(5):766-76. PubMed ID: 23432473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of neuronal excitability by immune mediators in epilepsy.
    Iori V; Frigerio F; Vezzani A
    Curr Opin Pharmacol; 2016 Feb; 26():118-23. PubMed ID: 26629681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain inflammation in a chronic epilepsy model: Evolving pattern of the translocator protein during epileptogenesis.
    Amhaoul H; Hamaide J; Bertoglio D; Reichel SN; Verhaeghe J; Geerts E; Van Dam D; De Deyn PP; Kumar-Singh S; Katsifis A; Van Der Linden A; Staelens S; Dedeurwaerdere S
    Neurobiol Dis; 2015 Oct; 82():526-539. PubMed ID: 26388398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astrocyte immune responses in epilepsy.
    Aronica E; Ravizza T; Zurolo E; Vezzani A
    Glia; 2012 Aug; 60(8):1258-68. PubMed ID: 22331574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epilepsy and innate immune system: A possible immunogenic predisposition and related therapeutic implications.
    Matin N; Tabatabaie O; Falsaperla R; Lubrano R; Pavone P; Mahmood F; Gullotta M; Serra A; Di Mauro P; Cocuzza S; Vitaliti G
    Hum Vaccin Immunother; 2015; 11(8):2021-9. PubMed ID: 26260962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
    Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
    Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.